Telangana partners with Cytiva to strengthen biopharma industry
Telangana partners with Cytiva to strengthen biopharma industry
23 February 2021 | News The 10,000 square foot lab, to be located in the Genome Valley, will accelerate and advance the local biopharma scale up needs
Cytiva, a global life science leader, and the State of Telangana in India will work together to open a new Fast Trak lab. The city of Hyderabad in Telangana, which has emerged as a leader in pharmaceuticals and biotechnology, is well-positioned to host such a facility. The 10,000 square foot lab, to be located in the Genome Valley, will accelerate and advance the local biopharma scale up needs.
Today in acquisitions: Flexiti, Athena Software, Vanrx Pharmasystems
This week, three Canadian startups and organizations have been involved in acquisition deals, including Flexiti, Athena Software, and Vanrx Pharmasystems. Here’s the latest on Canada’s movers and shakers.
Flexiti to be acquired for $155 million CAD
Toronto-based Flexiti Financial is set to be acquired by CURO, a United States-based firm that provides credit to non-prime consumers. The purchase price is expected to total up to $155 million CAD.
A spokesperson from Flexiti told BetaKit the deal is expected to close in four to six weeks.
Flexiti’s offering is currently accepted at nearly 6,000 locations and e-commerce sites across Canada.
Cytiva acquires Vanrx Pharmasystems, Canadian aseptic filling innovator
USA - English
Share this article
- Addition to portfolio supports global trends towards smaller manufacturing and the advent of personalized therapies
- First acquisition by company since becoming Cytiva in April 2020
AMERSHAM, United Kingdom, Feb. 1, 2021 /PRNewswire/ Cytiva has acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges with reduced risk and increased speed to patients.
SA25 Front Operator (PRNewsFoto/Cytiva)
This is the first acquisition by Cytiva. Emmanuel Ligner, President and CEO, Cytiva, says: Since becoming a Danaher operating company in April 2020, we have already begun fueling innovation and re-investing in the business for the benefit of our customers and their patients. We are thrilled to welcome the Vanrx associates to our family and look forward to working together on delivering meaningful soluti
01 febbraio 2021 06:48
Fonte: Adnkronos
#salute-e-benessere
- Cytiva will now provide idea to injection solutions to customers and the market
- Addition to portfolio supports global trends towards smaller manufacturing and the advent of personalized therapies
- First acquisition by company since becoming Cytiva in April 2020
AMERSHAM, United Kingdom, Feb. 1, 2021 /PRNewswire/ Cytiva has acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges with reduced risk and increased speed to patients.
This is the first acquisition by Cytiva. Emmanuel Ligner, President and CEO, Cytiva, says: Since becoming a Danaher operating company in April 2020, we have already begun fueling innovation and re-investing in the business for the benefit of our customers and their patients. We are thrilled to welcome the Vanrx associates to our family and look forward to working together on delivering meaningful solutio
/PRNewswire/ Cytiva, a global life sciences leader, has successfully completed another KUBio installation, this time to global healthcare solutions provider.